Place intelligence
The programmes, providers and market shifts changing wellness in United States.
The investigation closed at 131 reported cases across 38 states. Because the products last for years, that is not the same as the risk disappearing overnight.
The US beta connects wearable data, Energy Score and conversational answers. It is a glimpse of where every health dashboard is heading.
The July update reaches products sold for sexual enhancement, weight loss and muscle building—including formulas that may never make their real contents obvious.
The FDA database lists the DEP100 as an aesthetic electrical stimulator. Clearance is specific; it is not a blank cheque for every beauty claim around it.
Testing found DMAA, DMHA and phenibut. Only one product was voluntarily recalled, which leaves an uncomfortable gap between finding and removal.
Specific statements about cardiovascular risk, breast cancer and probable dementia have moved out of the most prominent warning box.